Feedback / Questions
AFNT-212 - Affini-T Therap
https://www.businesswire.com/news/home/20240407453794/en/Affini-T-Therapeutics-Presents-Preclinical-Data-from-its-Oncogenic-Driver-Programs-Targeting-KRAS-G12D-and-p53-R175H-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024
Apr 7, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next